Addex Therapeutics Ltd (ADXN) has a consensus analyst rating of Buy, based on 1 analyst covering the stock. Of those, 1 recommend buying, 0 recommend holding, and 0 recommend selling.
The analyst consensus price target for ADXN is $30.00, representing a +316.6% upside from the current price of $7.2004. Price targets range from a low of $30.00 to a high of $30.00.
